{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:18:19Z","timestamp":1793053099369,"version":"4.5.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R21DE033529"],"award-info":[{"award-number":["R21DE033529"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Periodontitis is a biofilm-induced chronic inflammatory disease, characterized by gingival inflammation and alveolar bone loss. According to a national survey, approximately half of the U.S. adults are affected by periodontal disease. To effectively prevent and treat periodontitis, it is essential to address its underlying causes. The primary etiological factors include polymicrobial synergy and dysbiosis of the oral microbiota, and a dysregulated immune response. The standard therapeutic approach, mechanical removal of biofilm through debridement, sometimes demonstrates limited efficacy, particularly in cases of severe periodontitis, which may require adjunctive or additional therapy. Emerging evidence indicates that periodontal tissue destruction is initiated by biofilm but primarily driven by a sustained, dysregulated host inflammatory response characterized by excessive cytokine production, osteoclast activation, and impaired inflammation resolution. In recent years, research has focused on targeting both the oral microbiota and immune response by utilizing antimicrobial therapeutics to diminish bacterial load and by modulating immune activity. Specifically, host modulation therapies (HMTs), such as the delivery of anti-inflammatory cytokines, nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose doxycycline, and lipid mediators, via various techniques, have been explored. However, challenges associated with its use encompass adverse effects resulting from prolonged administration, and systemic delivery methods are associated with an elevated risk of infection and the potential development of malignancy, as well as the disease rebound after cessation of treatment. This review examines current trends in HMTs for periodontitis and identifies potential limitations of these approaches. The insights gained may contribute to the development of improved strategies to enhance periodontal treatment outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1762187","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:41:36Z","timestamp":1771569696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Host modulation therapy in periodontitis: from established therapies to emerging technologies"],"prefix":"10.3389","volume":"17","author":[{"given":"Aonjittra","family":"Phanrungsuwan","sequence":"first","affiliation":[{"name":"Department of Periodontics and Dental Hygiene, School of Dentistry, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Dental Hygiene, School of Dentistry, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraja","family":"Dharmaraj","sequence":"additional","affiliation":[{"name":"Katz Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Cobos Perez","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Veiseh","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Young","sequence":"additional","affiliation":[{"name":"Katz Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Teh","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Dental Hygiene, School of Dentistry, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.adaj.2018.04.023","article-title":"Periodontitis in US adults: national health and nutrition examination survey 2009-2014","volume":"149","author":"Eke","year":"2018","journal-title":"J Am Dent Assoc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/0022034517750572","article-title":"Global-, regional-, and country-level economic impacts of dental diseases in 2015","volume":"97","author":"Righolt","year":"2018","journal-title":"J Dent Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0140-6736(24)02811-3","article-title":"Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/08959374940080022001","article-title":"Microbial ecology of dental plaque and its significance in health and disease","volume":"8","author":"Marsh","year":"1994","journal-title":"Adv Dent Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2008.080279","article-title":"Inflammation and periodontal diseases: a reappraisal","volume":"79","author":"Van Dyke","year":"2008","journal-title":"J Periodontol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00511","article-title":"The nexus between periodontal inflammation and dysbiosis","volume":"11","author":"Van Dyke","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1993.64.8s.828","article-title":"Blocking periodontal disease progression with anti-inflammatory agents","volume":"64","author":"Howell","year":"1993","journal-title":"J Periodontol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/10454411930040020301","article-title":"Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression","volume":"4","author":"Howell","year":"1993","journal-title":"Crit Rev Oral Biol Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1989.60.9.485","article-title":"Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen","volume":"60","author":"Williams","year":"1989","journal-title":"J Periodontol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.semarthrit.2008.08.001","article-title":"Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention","volume":"39","author":"Vonkeman","year":"2010","journal-title":"Semin Arthritis Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12148","article-title":"Host modulation therapy with anti-inflammatory agents","volume":"76","author":"Preshaw","year":"2018","journal-title":"Periodontol 2000"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2012.120009","article-title":"Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-\u03b1 therapy","volume":"84","author":"Mayer","year":"2013","journal-title":"J Periodontol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.17796\/1053-4628-39.4.326","article-title":"Early Colonization of Lactobacillus reuteri after Exposure to Probiotics","volume":"39","author":"\u00c7aglar","year":"2015","journal-title":"J Clin Pediatr Dent"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00757","article-title":"Role of","volume":"9","author":"Mu","year":"2018","journal-title":"Front Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2001.37","article-title":"Lactococcus lactis, a tool for the delivery of therapeutic proteins treatment of IBD","volume":"1","author":"Steidler","year":"2001","journal-title":"ScientificWorldJournal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of\u00a0murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.028","article-title":"A\u00a0phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease","volume":"4","author":"Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.01.010","article-title":"Gut microbiota in cancer immune response and immunotherapy","volume":"7","author":"Zhou","year":"2021","journal-title":"Trends Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2020-19625","article-title":"Fermented milk with Lactobacillus curvatus SMFM2016-NK alleviates periodontal and gut inflammation, and alters oral and gut microbiota","volume":"104","author":"Choi","year":"2021","journal-title":"J Dairy Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.12387","article-title":"Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study","volume":"42","author":"Tekce","year":"2015","journal-title":"J Clin Periodontol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2015.140612","article-title":"Clinical and biochemical evaluation of lozenges containing lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis","volume":"86","author":"\u0130nce","year":"2015","journal-title":"J Periodontol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.12155","article-title":"Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study","volume":"40","author":"Teughels","year":"2013","journal-title":"J Clin Periodontol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"108823","DOI":"10.1016\/j.clim.2021.108823","article-title":"ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease","volume":"230","author":"Zanin-Zhorov","year":"2021","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.822303","article-title":"SGK1, a critical regulator of immune modulation and fibrosis and a potential therapeutic target in chronic graft-versus-host disease","volume":"13","author":"Lu","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104533","DOI":"10.1016\/j.ebiom.2023.104533","article-title":"Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites","volume":"91","author":"Gao","year":"2023","journal-title":"EBioMedicine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1341-1","article-title":"Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer","volume":"39","author":"Fong","year":"2020","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200066","article-title":"UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis","volume":"134","author":"Bedi","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.01.017","article-title":"Modulating the microbiome for crohn\u2019s disease treatment","volume":"164","author":"Gowen","year":"2023","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","article-title":"Innate immune training of granulopoiesis promotes anti-tumor activity","volume":"183","author":"Kalafati","year":"2020","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2002.73.4.460","article-title":"Informational paper: modulation of the host response in periodontal therapy","volume":"73","year":"2002","journal-title":"J Periodontol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/prd.12331","article-title":"Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy","volume":"84","author":"Hajishengallis","year":"2020","journal-title":"Periodontol 2000"},{"key":"B34","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1177\/0022034521995157","article-title":"Host modulation and treatment of periodontal disease","volume":"100","author":"Balta","year":"2021","journal-title":"J Dent Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fdmed.2024.1423401","article-title":"Host modulation therapy in periodontitis, diagnosis and treatment-status update","volume":"5","author":"Golub","year":"2024","journal-title":"Front Dent Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/prd.12002","article-title":"Inflammatory and immune pathways in the pathogenesis of periodontal disease","volume":"64","author":"Cekici","year":"2014","journal-title":"Periodontol 2000"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053764878","article-title":"The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases","volume":"11","author":"Salvi","year":"2005","journal-title":"Curr Pharm Des"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.71.6.1009","article-title":"Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats","volume":"71","author":"Bezerra","year":"2000","journal-title":"J Periodontol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7861\/clinmed.2021-0039","article-title":"Non-steroidal anti-inflammatory drugs and the gastrointestinal tract","volume":"21","author":"Tai","year":"2021","journal-title":"Clin Med (Lond)."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600859","article-title":"Resolvin E1 reverses experimental periodontitis and dysbiosis","volume":"197","author":"Lee","year":"2016","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.7021","article-title":"Resolvin E1 regulates inflammation at the cellular and tissue level and restores\u00a0tissue homeostasis in vivo","volume":"179","author":"Hasturk","year":"2007","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mam.2017.04.006","article-title":"Pro-resolving mediators in the regulation of periodontal disease","volume":"58","author":"Van Dyke","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704163","article-title":"Safety and preliminary efficacy of a novel host-modulatory therapy for reducing gingival inflammation","volume":"12","author":"Hasturk","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2004.75.1.106","article-title":"The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis","volume":"75","author":"Emingil","year":"2004","journal-title":"J\u00a0Periodontol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1479152","article-title":"Systemic doxycycline as an adjunct to nonsurgical periodontal therapy in diabetic patients with periodontitis: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.adaj.2015.01.028","article-title":"Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts","volume":"146","author":"Smiley","year":"2015","journal-title":"J Am Dent Assoc"},{"key":"B47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1600-051X.2004.00558.x","article-title":"Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review","volume":"31","author":"Preshaw","year":"2004","journal-title":"J Clin Periodontol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1647066","article-title":"Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions","volume":"16","author":"Alsayb","year":"2025","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2018.12.004","article-title":"Cytokine therapy","volume":"33","author":"Silk","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/03008200390152061","article-title":"Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins","author":"Fisher","year":"2003","journal-title":"Connect Tissue Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"284836","DOI":"10.1155\/2014\/284836","article-title":"Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases","volume":"2014","author":"Zhang","year":"2014","journal-title":"BioMed Res Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1435054","article-title":"Cytokines in gingivitis and periodontitis: from pathogenesis\u00a0to therapeutic targets","volume":"15","author":"Neurath","year":"2024","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1177\/154405910708600614","article-title":"IL-10 gene transfer attenuates P. gingivalis-induced inflammation","volume":"86","author":"Houri-Haddad","year":"2007","journal-title":"J Dent Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00009","article-title":"Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation","volume":"10","author":"Cohen","year":"2004","journal-title":"Inflammation Bowel Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0722.2006.00283.x","article-title":"Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle","volume":"114","author":"Liu","year":"2006","journal-title":"Eur J Oral Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612197","article-title":"Interleukin-12 and interleukin-23 blockade in leukocyte adhesion deficiency type 1","volume":"376","author":"Moutsopoulos","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13872","article-title":"CCL2 is a key regulator and therapeutic target for periodontitis","volume":"50","author":"Jiang","year":"2023","journal-title":"J Clin Periodontol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s40496-017-0159-6","article-title":"Use of probiotics and oral health","volume":"4","author":"Allaker","year":"2017","journal-title":"Curr Oral Health Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12164","article-title":"Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss","volume":"49","author":"Maekawa","year":"2014","journal-title":"J\u00a0Periodontal Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41598-017-00623-9","article-title":"Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Sci Rep"},{"key":"B64","first-page":"42","article-title":"Probiotics and periodontitis - A literature review","volume":"19","author":"Gatej","year":"2017","journal-title":"J Int Acad Periodontol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12332","article-title":"Modulation of the host response by\u00a0probiotic Lactobacillus brevis CD2 in experimental gingivitis","volume":"21","author":"Lee","year":"2015","journal-title":"Oral Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.12545","article-title":"Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis","volume":"43","author":"Martin-Cabezas","year":"2016","journal-title":"J Clin Periodontol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10544-015-9944-y","article-title":"Drug coated microneedles for minimally-invasive treatment of oral carcinomas: development and in vitro evaluation","volume":"17","author":"Ma","year":"2015","journal-title":"BioMed Microdevices"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.matt.2021.11.017","article-title":"Immunomodulatory microneedle patch for periodontal tissue regeneration","volume":"5","author":"Zhang","year":"2022","journal-title":"Matter"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1335-1","article-title":"Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity","volume":"31","author":"Ma","year":"2014","journal-title":"Pharm Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13346-021-00922-9","article-title":"Non-dermal applications of microneedle drug delivery systems","volume":"12","author":"Panda","year":"2022","journal-title":"Drug Delivery Transl Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm1032","article-title":"Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors","volume":"8","author":"Nash","year":"2022","journal-title":"Sci Adv"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/00016357.2017.1292427","article-title":"Effect of local hIL-10 gene therapy on experimental periodontitis in ovariectomized rats","volume":"75","author":"Li","year":"2017","journal-title":"Acta Odontol Scand"},{"key":"B73","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41522-024-00614-5","article-title":"Probiotics as an adjunctive therapy in periodontitis treatment-reality or illusion-a clinical perspective","volume":"10","author":"Baddouri","year":"2024","journal-title":"NPJ Biofilms Microbiomes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1762187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:41:38Z","timestamp":1771569698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1762187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2026.1762187"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1762187","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"article-number":"1762187"}}